PPP2R5D-related intellectual disability
آخر تحديث 1 Feb 2021
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
PPP2R5D-related intellectual disability is a neurological disorder characterised by moderate to severe developmental delay and intellectual disability. Affected individuals have weak muscle tone (hypotonia); delayed development of motor skills, such as sitting, standing, and walking; and delayed speech development. Recurrent seizures (epilepsy) and autism spectrum disorder, which is characterised by impaired communications and social interaction, can also occur in affected individuals. Most people with PPP2R5D-related intellectual disability have an unusually large head size (macrocephaly), and some have other unusual facial features, including a prominent forehead (frontal bossing), widely spaced eyes (hypertelorism), and eyes that slant downward (downslanting palpebral fissures).
اختيارات الفيديو لـ الحالات الوراثيةمكتبة الفيديو
الوصف
PPP2R5D-related intellectual disability is a neurological disorder characterised by moderate to severe developmental delay and intellectual disability. Affected individuals have weak muscle tone (hypotonia); delayed development of motor skills, such as sitting, standing, and walking; and delayed speech development. Recurrent seizures (epilepsy) and autism spectrum disorder, which is characterised by impaired communications and social interaction, can also occur in affected individuals. Most people with PPP2R5D-related intellectual disability have an unusually large head size (macrocephaly), and some have other unusual facial features, including a prominent forehead (frontal bossing), widely spaced eyes (hypertelorism), and eyes that slant downward (downslanting palpebral fissures).
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
Autosomal dominant mental retardation 35
Related patient information and medicines

Patient information leaflet
الشلل الدماغي
It is caused by brain injury or abnormal development of the brain that occurs while a child's brain is still developing. What is cerebral palsy. Cerebral palsy is a name for a group of life-long conditions that have problems with muscle function and control. Most people think o... Some people with cerebral palsy also have other problems such as.

Patient information leaflet
الأطفال الخُدّج
However about 1 in 10 of all prematur... One study of 241 children born before 26 weeks of gestation found: 1 in 5 had severe disability (على سبيل المثال،, الشلل الدماغي + not walking, low cognitive scores, blindness, profound deafness). 1 in 4 had moderate disability (على سبيل المثال،, الشلل الدماغي + walking, IQ/cognitive scores in the special needs.

Patient information leaflet
عسر القراءة
Dyslexia is common. It is usually first noticed during the first few years at school. What is dyslexia. Dyslexia is a specific learning difficulty that causes problems with reading, writing and spelling. Dyslexia is a lifelong problem but help and support is available to help improve reading and writing skills and achieve success at school and at.

Patient information leaflet
متلازمة بكاء القط
متلازمة بكاء القط is a chromosome problem caused by a missing piece of chromosome 5. The syndrome is called cri du chat (French for cry of the cat) because affected babies often have a high-pitched cry. However, most people with cri du chat syndrome survive well into adulthood. About 1 in 10 babies born with cri du chat syndrome are severely.

Patient information leaflet
متلازمة داون
متلازمة داون (also known as Down syndrome) is a genetic chromosome problem. Someone with Down's syndrome has an extra copy of chromosome 21 in the cells of their body. This causes the typical features of the condition. All people with Down's syndrome have some degree of learning disability. They are also at increased chance of having various.

Patient information leaflet
الصرع وتخطيط الحمل
By enrolling with the UK الصرع and Pregnancy Register if you are pregnant and have epilepsy, you will help to give doctors a clearer picture of which medicines are safest for babies' health. ...oate medicine is linked to a higher risk than some other epilepsyEditor's note Dr Krishna Vakharia , 1st July 2024 The MHRA has introduced new safety.
قراءة إضافية ومراجع
- PPP2R5D-related intellectual disability; MedlinePlus, National Library of Medicine.
- Houge G, Haesen D, Vissers LE, Mehta S, Parker MJ, Wright M, Vogt J, McKee S, Tolmie JL, Cordeiro N, Kleefstra T, Willemsen MH, Reijnders MR, Berland S, Hayman E, Lahat E, Brilstra EH, van Gassen KL, Zonneveld-Huijssoon E, de Bie CI, Hoischen A, Eichler EE, Holdhus R, Steen VM, Doskeland SO, Hurles ME, FitzPatrick DR, Janssens V. B56delta-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. J Clin Invest. 2015 Aug 3;125(8):3051-62. doi: 10.1172/JCI79860. Epub 2015 Jul 13.
- Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001 Feb 1;353(Pt 3):417-39. doi: 10.1042/0264-6021:3530417.
- Loveday C, Tatton-Brown K, Clarke M, Westwood I, Renwick A, Ramsay E, Nemeth A, Campbell J, Joss S, Gardner M, Zachariou A, Elliott A, Ruark E, van Montfort R; Childhood Overgrowth Collaboration; Rahman N. Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth. Hum Mol Genet. 2015 Sep 1;24(17):4775-9. doi: 10.1093/hmg/ddv182. Epub 2015 May 13.
- Shang L, Henderson LB, Cho MT, Petrey DS, Fong CT, Haude KM, Shur N, Lundberg J, Hauser N, Carmichael J, Innis J, Schuette J, Wu YW, Asaikar S, Pearson M, Folk L, Retterer K, Monaghan KG, Chung WK. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism. Neurogenetics. 2016 Jan;17(1):43-9. doi: 10.1007/s10048-015-0466-9. Epub 2015 Nov 17.
- Yu UY, Yoo BC, Ahn JH. Regulatory B Subunits of Protein Phosphatase 2A Are Involved in Site-specific Regulation of Tau Protein Phosphorylation. Korean J Physiol Pharmacol. 2014 Apr;18(2):155-61. doi: 10.4196/kjpp.2014.18.2.155. Epub 2014 Apr 3.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
1 Feb 2021 | أحدث إصدار
1 أغسطس 2017 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

